ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,827.04
      -1.54%
      US Tech 100
      20,287.60
      0.00%
      Dow Jones
      41,938.45
      -1.63%
      Brent Oil
      80.505
      -0.14%
      Bitcoin
      93,290.56
      -1.27%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Cosmo Pharmaceuticals Nv (0RGI) Quote

      Cosmo Pharmaceuticals Nv

      Cosmo Pharmaceuticals Nv (0RGI)

      LSE
      126.90
      0.00
      ( 0.00% )
      Updated: 19:00:00
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      126.90
      Bid
      0.00
      Ask
      0.00
      Volume
      0.00
      0.00 Day's Range 0.00
      126.90 52 Week Range 126.90
      Market Cap
      2.226B
      Previous Close
      126.90
      Open
      -
      Last Trade
      (O)
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      590
      Shares Outstanding
      17,543,000
      Dividend Yield
      -
      PE Ratio
      -451.44
      Earnings Per Share (EPS)
      -0.28
      Revenue
      94.23M
      Net Profit
      -4.93M

      About Cosmo Pharmaceuticals Nv

      Sector
      Pharmaceutical Preparations
      Industry
      Medicinal Chems,botanicl Pds
      Website
      www.cosmopharmaceuticals.com
      Headquarters
      Dublin, Irl
      Founded
      1997
      Cosmo Pharmaceuticals Nv is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0RGI. The last closing price for Cosmo Pharmaceuticals Nv was CHF126.90. Over the last year, Cosmo Pharmaceuticals Nv shares have traded in a share price range of CHF 126.90 to CHF 126.90.

      Cosmo Pharmaceuticals Nv currently has 17,543,000 shares outstanding. The market capitalization of Cosmo Pharmaceuticals Nv is CHF2.23 billion. Cosmo Pharmaceuticals Nv has a price to earnings ratio (PE ratio) of -451.44.

      Ask ADVFN Intelligence (AI)

      0RGI Latest News

      More News

      Invitation to Cosmo's GI Genius™ Q&A session for investors, analysts and journalist

      Invitation to Cosmo's GI Genius™ Q&A session for investors, analysts and journalist PR Newswire DUBLIN, April 28, 2021 DUBLIN, April 28, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX:...

      April 28 2021
      PR Newswire (US)

      Cosmo announces FDA approval of GI Genius™ intelligent endoscopy module, its revolutionary Artificial Intelligence device f...

      Cosmo announces FDA approval of GI Genius™ intelligent endoscopy module, its revolutionary Artificial Intelligence device for lesion detection during colonoscopy PR Newswire DUBLIN, April 12...

      April 12 2021
      PR Newswire (US)

      Cosmo Full-Year Report 2020: Cosmo returns to operating profit

      Cosmo Full-Year Report 2020: Cosmo returns to operating profit PR Newswire DUBLIN, March 26, 2021 DUBLIN, March 26, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX: COPN) reports Full-Year...

      March 26 2021
      PR Newswire (US)

      Invitation to Cosmo's 2020 results / 2021 outlook presentation conference call on 26 March 2021

      Invitation to Cosmo's 2020 results / 2021 outlook presentation conference call on 26 March 2021 PR Newswire DUBLIN, March 19, 2021 DUBLIN, March 19, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals NV...

      March 19 2021
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      100126.9126.9126.9406126.9DE
      400126.9126.9126.9451126.9DE
      1200126.9126.9126.9590126.9DE
      2600126.9126.9126.9586126.9DE
      5200126.9126.9126.9861126.9DE
      15600126.9126.9126.91122126.9DE
      26000126.9126.9126.9924126.9DE

      0RGI - Frequently Asked Questions (FAQ)

      What is the current Cosmo Pharmaceuticals Nv share price?
      The current share price of Cosmo Pharmaceuticals Nv is CHF 126.90
      How many Cosmo Pharmaceuticals Nv shares are in issue?
      Cosmo Pharmaceuticals Nv has 17,543,000 shares in issue
      What is the market cap of Cosmo Pharmaceuticals Nv?
      The market capitalisation of Cosmo Pharmaceuticals Nv is CHF 2.23B
      What is the 1 year trading range for Cosmo Pharmaceuticals Nv share price?
      Cosmo Pharmaceuticals Nv has traded in the range of CHF 126.90 to CHF 126.90 during the past year
      What is the PE ratio of Cosmo Pharmaceuticals Nv?
      The price to earnings ratio of Cosmo Pharmaceuticals Nv is -451.44
      What is the cash to sales ratio of Cosmo Pharmaceuticals Nv?
      The cash to sales ratio of Cosmo Pharmaceuticals Nv is 23.62
      What is the reporting currency for Cosmo Pharmaceuticals Nv?
      Cosmo Pharmaceuticals Nv reports financial results in EUR
      What is the latest annual turnover for Cosmo Pharmaceuticals Nv?
      The latest annual turnover of Cosmo Pharmaceuticals Nv is EUR 94.23M
      What is the latest annual profit for Cosmo Pharmaceuticals Nv?
      The latest annual profit of Cosmo Pharmaceuticals Nv is EUR -4.93M
      What is the registered address of Cosmo Pharmaceuticals Nv?
      The registered address for Cosmo Pharmaceuticals Nv is RIVERSIDE II, SIR JOHN ROGERSON’S QUAY, DUBLIN, 20020
      What is the Cosmo Pharmaceuticals Nv website address?
      The website address for Cosmo Pharmaceuticals Nv is www.cosmopharmaceuticals.com
      Which industry sector does Cosmo Pharmaceuticals Nv operate in?
      Cosmo Pharmaceuticals Nv operates in the MEDICINAL CHEMS,BOTANICL PDS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      0A2IH World Group Ltd
      $ 0.00
      (0.00%)
      		0
      0A2DCrh Plc
      $ 0.00
      (0.00%)
      		0
      0A2BBanco Bilbao Vizcaya Argentaria Sa
      $ 0.00
      (0.00%)
      		0
      0A22Anheuser Busch Inbev Nv
      $ 0.00
      (0.00%)
      		0
      0A1UUber Technologies Inc
      $ 66.00
      (0.00%)
      		1.65k
      0A2IH World Group Ltd
      $ 0.00
      (0.00%)
      		0
      0A2DCrh Plc
      $ 0.00
      (0.00%)
      		0
      0A2BBanco Bilbao Vizcaya Argentaria Sa
      $ 0.00
      (0.00%)
      		0
      0A22Anheuser Busch Inbev Nv
      $ 0.00
      (0.00%)
      		0
      0A1UUber Technologies Inc
      $ 66.00
      (0.00%)
      		1.65k
      0R0XTesla Inc
      $ 388.20
      (0.00%)
      		4.74k
      0JOQJd.com Inc
      $ 72.00
      (0.00%)
      		3.03k
      0HCIAlibaba Group Holding Ltd
      $ 81.10
      (0.00%)
      		2.3k
      0R1OAmazon.com Inc
      $ 217.50
      (0.00%)
      		1.67k
      0P4FFord Motor Co
      $ 9.665
      (0.00%)
      		1.67k

      Discussion

      View Full Feed
      DiamondHealer95 DiamondHealer95 3 minutes ago
      I mean Kim said once they hit 1.5 metric tons they're open for business and they're about halfway there so..... You're a genius! Congrats on the business. I also run one with 100% positive feedback over 22 years 🤪
      KBLB
      DiamondHealer95 DiamondHealer95 7 minutes ago
      We've invested similarly
      KBLB
      sunspotter sunspotter 18 minutes ago
      Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
      VPLM
      Flobewan Flobewan 29 minutes ago
      Marc loved your ides
      tinojax tinojax 30 minutes ago
      I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
      PLUG
      mrfence mrfence 32 minutes ago
      Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
      [yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
      FMCC FNMA
      IVRT IVRT 49 minutes ago
      In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
      BMXI
      DewDiligence DewDiligence 49 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      ENTA
      DewDiligence DewDiligence 50 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      Guido2 Guido2 51 minutes ago
      This is DUE DILIGENCE! Thank you Free Fannie.

      https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
      FNMA
      StockItOut StockItOut 57 minutes ago
      That Xeriant PR excellently written with bullshit:

      ""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

      "the Company used the data to make several key
      XERI
      gitreal gitreal 1 hour ago
      You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
      BMXI
      RichieBoy RichieBoy 1 hour ago
      Jim wrote a blurb about seeking more US business.

      Help you out any? 🤨
      AFFU
      DesktopDR DesktopDR 1 hour ago
      Any news or updates?
      VPLM
      Tahoe2468 Tahoe2468 1 hour ago
      .0915 by Thursday....... 
      KRTL
      skitahoe skitahoe 1 hour ago
      Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

      According to Google, GBM ha
      NWBO
      fuagf fuagf 1 hour ago
      You are right about the crafty, evil, smart. Authoritarian methods have been in full view
      in capturing America. While we work to do the right things they plot to capture the lot.
      facts_matter14 facts_matter14 1 hour ago
      If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






      .
      SRMX
      StockItOut StockItOut 1 hour ago
      Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
      XERI
      fuagf fuagf 1 hour ago
      He would smother any question with words.
      Shawonsarker84 Shawonsarker84 1 hour ago
      $HMBL Sorry HMBL investors. XTIA now broke the record 2.7B share volume traded before the reverse split.



      https://x.com/shawonsarker84/status/1878696680088019193?t=rZlhkn2Jos4vWKxxQgXGfA&s=19
      HMBL XTIA
      chen1992 chen1992 1 hour ago
      https://www.energy.senate.gov/hearings/2025/1/hearing-to-consider-the-nomination-of-mr-chris-wright-to-be-secretary-of-energy

      https://www.commerce.senate.gov/2025/1/full-committee-nomination-hearing_2#:~:text=U.S.%20Senator%20Ted%20Cruz%20(R,Wednesday%2C%20January%2015%2C%20
      TGLO
      FNM500K FNM500K 1 hour ago
      Oh noooooo.....
      FNMA
      StockItOut StockItOut 2 hours ago
      OTC filings and attorney statements. my error.

      Point that it is on you to prove your claim, that:
      "There's no contract employees. There's no production shafts."

      Likewise for the company to do so, as we wait for an audit, apparently indefinitely.

      I
      BMXI

      Your Recent History

      LSE
      0RGI
      Cosmo Pharmaceuticals Nv
      USOTC
      BAUFF
      Blue Star Gold (QB)
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads